Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Adjuvant Global Health Technology Fund, L.P.
10% owner at AN2 Therapeutics. Filing since 29 Mar 2022.
CIK 0001783165
Company
Date
Role
Action
Shares
Amount
Of holding
ANTX
AN2 Therapeutics, Inc.
16 Jan 2024
10% owner
Sold at will
84,093
$1.65M
4.0%
ANTX
AN2 Therapeutics, Inc.
16 Jan 2024
10% owner
Sold at will
15,907
$312.57K
4.0%
ANTX
AN2 Therapeutics, Inc.
14 Nov 2023
10% owner
Sold on a plan
1,522
$24.57K
0.1%
ANTX
AN2 Therapeutics, Inc.
14 Nov 2023
10% owner
Sold on a plan
288
$4.65K
0.1%
ANTX
AN2 Therapeutics, Inc.
2 Oct 2023
10% owner
Sold at will
4,770
$76.65K
0.2%
ANTX
AN2 Therapeutics, Inc.
2 Oct 2023
10% owner
Sold at will
902
$14.50K
0.2%
ANTX
AN2 Therapeutics, Inc.
29 Sep 2023
10% owner
Sold at will
83,337
$1.36M
3.8%
ANTX
AN2 Therapeutics, Inc.
29 Sep 2023
10% owner
Sold at will
15,764
$256.64K
3.8%
ANTX
AN2 Therapeutics, Inc.
28 Sep 2023
10% owner
Sold at will
7,160
$115.35K
0.3%
ANTX
AN2 Therapeutics, Inc.
28 Sep 2023
10% owner
Sold at will
1,356
$21.85K
0.3%
ANTX
AN2 Therapeutics, Inc.
27 Sep 2023
10% owner
Sold at will
707
$11.36K
0.0%
ANTX
AN2 Therapeutics, Inc.
27 Sep 2023
10% owner
Sold at will
134
$2.15K
0.0%
ANTX
AN2 Therapeutics, Inc.
13 Sep 2023
10% owner
Sold at will
336
$5.38K
0.0%
ANTX
AN2 Therapeutics, Inc.
13 Sep 2023
10% owner
Sold at will
64
$1.02K
0.0%
ANTX
AN2 Therapeutics, Inc.
7 Sep 2023
10% owner
Sold at will
2,841
$45.60K
0.1%
ANTX
AN2 Therapeutics, Inc.
7 Sep 2023
10% owner
Sold at will
537
$8.62K
0.1%
ANTX
AN2 Therapeutics, Inc.
6 Sep 2023
10% owner
Sold at will
3,164
$50.69K
0.1%
ANTX
AN2 Therapeutics, Inc.
6 Sep 2023
10% owner
Sold at will
598
$9.58K
0.1%
ANTX
AN2 Therapeutics, Inc.
23 Aug 2023
10% owner
Sold at will
336
$5.38K
0.0%
ANTX
AN2 Therapeutics, Inc.
23 Aug 2023
10% owner
Sold at will
64
$1.02K
0.0%
ANTX
AN2 Therapeutics, Inc.
29 Mar 2022
10% owner
Bought
166,666
$2.50M
8.2%
21 decisions on file.
